Heinrich Dreismann, Director at MYRIAD GENETICS INC (MYGN), sold 6,000 shares at $33.50 ($201K) on 2017-12-11, disclosed to the SEC on 2017-12-12.
Seasonal sale ($201k) by Director — this insider has traded MYGN in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| MYGN | SELL | 2014-02-20 | $1.1M | — | Filing → |
| MYGN | SELL | 2013-05-10 | $935K | — | Filing → |